Agios Pharmaceuticals, Inc. 2025 Q3 – Results – Earnings Call Presentation (NASDAQ:AGIO) 2025-11-04
Q3: 2025-10-30 Earnings SummaryEPS of -$1.78 beats by $0.12 | Revenue of $12.88M (43.69% Y/Y) beats by $2.27MThis article was written...
Pharmaceuticals
ARS Pharmaceuticals: A Significant Upside Is Expected From neffy (NASDAQ:SPRY)
This article was written byFollow"Fundamental Options" would be the title of my investing style, because I combine fundamental analysis with...
Arrowhead Pharmaceuticals, Inc. (ARWR) Cantor Global Healthcare Conference 2025 Transcript
FollowPlay Earnings CallPlay Earnings CallArrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Cantor Global Healthcare Conference 2025 September 4, 2025 9:10 AM EDT Company...
Industry Analysis: Eli Lilly Stock Tops My Tier Two Pharmaceuticals List (NYSE:LLY)
This article was written byFollowFounder of Bern Factor LLC, an independent research and publishing firm located in Virginia. I have...
Regeneron Pharmaceuticals, Inc. (REGN) Presents at 46th Annual Goldman Sachs Global Healthcare Conference Transcript
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) 46th Annual Goldman Sachs Global Healthcare Conference June 9, 2025 10:40 AM ET Company Participants Christopher...
Tarsus Pharmaceuticals: Strong Execution In Eye Disease Treatment (NASDAQ:TARS)
Pgiam/iStock via Getty ImagesTarsus Pharma (NASDAQ:TARS) has an approved drug for a mite infestation eye disease called Demodex blepharitis and...
